Quick Answer
Elevance Health, Inc. reported Stockholders Equity of $43.88 billion for fiscal year 2025.
Elevance Health, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $43.88B | +6.2% |
| 2024 | $41.31B | +5.1% |
| 2023 | $39.31B | +8.5% |
| 2022 | $36.24B | +0.5% |
| 2021 | $36.06B | +8.6% |
| 2020 | $33.20B | +4.6% |
| 2019 | $31.73B | +11.2% |
| 2018 | $28.54B | +7.7% |
| 2017 | $26.50B | +5.6% |
| 2016 | $25.10B | +8.9% |
| 2015 | $23.05B | -5.0% |
| 2014 | $24.25B | -2.1% |
| 2013 | $24.77B | +4.0% |
| 2012 | $23.80B | +2.2% |
| 2011 | $23.29B | -2.2% |
| 2010 | $23.81B | -4.2% |
| 2009 | $24.86B | +16.0% |
| 2008 | $21.43B | -6.8% |
| 2007 | $22.99B | -6.5% |
| 2006 | $24.58B | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $43.95B | +0.4% | +0.5% |
| June 30, 2025 | $43.72B | +3.6% | +2.9% |
| March 31, 2025 | $42.50B | +4.7% | +2.9% |
| December 31, 2024 | $41.31B | +5.1% | -5.6% |
| September 30, 2024 | $43.77B | +13.9% | +3.8% |
| June 30, 2024 | $42.19B | +10.4% | +3.9% |
| March 31, 2024 | $40.61B | +8.7% | +3.3% |
| December 31, 2023 | $39.31B | +8.5% | +2.3% |
- Elevance Health, Inc. showed an increase of +6.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2006–2025 period, Elevance Health, Inc.’s stockholders equity has grown by 78.6% (from $24.58 billion to $43.88 billion).
- The most recent figure is from Elevance Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: